# COVID-19 Convalescent Plasma Treatment in SARS-CoV-2 Infected Patients

> **NCT04474340** · PHASE1 · UNKNOWN · sponsor: **Ministry of Health, Kuwait** · enrollment: 300 (estimated)

## Conditions studied

- Moderate COVID-19 Pneumonia, Severe COVID-19 Pneumonia
- Pneumonia, Viral

## Interventions

- **DRUG:** COVID-19 Convalscent Plasma

## Key facts

- **NCT ID:** NCT04474340
- **Lead sponsor:** Ministry of Health, Kuwait
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-05-21
- **Primary completion:** 2020-09-30
- **Final completion:** 2020-12-30
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2020-07-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04474340

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04474340, "COVID-19 Convalescent Plasma Treatment in SARS-CoV-2 Infected Patients". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04474340. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*